TScan Therapeutics
  • About
    • Our Company
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Partners

    About TScan

    TScan is dedicated to changing lives by discovering new cancer targets and developing safe and effective T-cell therapies for patients.

  • Technology
    • Our Approach
    • TargetScan
    • ReceptorScan
    • T-Integrate Cell Engineering
    • Publications

    Technology

    TScan’s therapeutic approach is based on the central premise that we can learn from patients who are winning their fight against cancer in order to treat those who are not.

  • Investors and Media
  • Pipeline
  • Careers
  • About
    • Our Company
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Partners
  • Technology
    • Our Approach
    • TargetScan
    • ReceptorScan
    • T-Integrate Cell Engineering
    • Publications
  • Investors and Media
  • Pipeline
  • Careers

About

Leadership

  • Management
  • Board of Directors
  • Advisory Board

David Southwell

Chief Executive Officer

Gavin MacBeath, Ph.D.

Chief Scientific Officer

Brian M. Silver

Chief Financial Officer

Bill Desmarais, Ph.D.

Chief Business Officer

Zoran Zdraveski, J.D., Ph.D.

Chief Legal Officer

Shrikanta Chattopadhyay, M.D.

VP of Medical

Cagan Gurer, Ph.D.

VP of Discovery

Ann Hargraves

VP of Human Resources

Jim Murray

VP of Clinical Operations

Ken Olivier, Ph.D.

VP of Non-clinical Development

Interested in joining our team? Explore Careers

©2022 TScan Therapeutics
  • Contact
  • Privacy policy
  • Terms and conditions